1. Home
  2. IKNA vs VGZ Comparison

IKNA vs VGZ Comparison

Compare IKNA & VGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • VGZ
  • Stock Information
  • Founded
  • IKNA 2016
  • VGZ 1983
  • Country
  • IKNA United States
  • VGZ United States
  • Employees
  • IKNA N/A
  • VGZ N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • VGZ
  • Sector
  • IKNA Health Care
  • VGZ
  • Exchange
  • IKNA Nasdaq
  • VGZ Nasdaq
  • Market Cap
  • IKNA 80.8M
  • VGZ 78.7M
  • IPO Year
  • IKNA 2021
  • VGZ N/A
  • Fundamental
  • Price
  • IKNA $1.71
  • VGZ $0.60
  • Analyst Decision
  • IKNA Buy
  • VGZ Strong Buy
  • Analyst Count
  • IKNA 2
  • VGZ 1
  • Target Price
  • IKNA $3.00
  • VGZ $2.75
  • AVG Volume (30 Days)
  • IKNA 60.6K
  • VGZ 466.8K
  • Earning Date
  • IKNA 11-07-2024
  • VGZ 10-23-2024
  • Dividend Yield
  • IKNA N/A
  • VGZ N/A
  • EPS Growth
  • IKNA N/A
  • VGZ N/A
  • EPS
  • IKNA N/A
  • VGZ 0.09
  • Revenue
  • IKNA $659,000.00
  • VGZ N/A
  • Revenue This Year
  • IKNA N/A
  • VGZ N/A
  • Revenue Next Year
  • IKNA N/A
  • VGZ N/A
  • P/E Ratio
  • IKNA N/A
  • VGZ $6.60
  • Revenue Growth
  • IKNA N/A
  • VGZ N/A
  • 52 Week Low
  • IKNA $1.22
  • VGZ $0.30
  • 52 Week High
  • IKNA $2.32
  • VGZ $0.83
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 49.85
  • VGZ 47.24
  • Support Level
  • IKNA $1.71
  • VGZ $0.54
  • Resistance Level
  • IKNA $1.77
  • VGZ $0.69
  • Average True Range (ATR)
  • IKNA 0.05
  • VGZ 0.04
  • MACD
  • IKNA -0.00
  • VGZ 0.00
  • Stochastic Oscillator
  • IKNA 38.46
  • VGZ 69.13

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About VGZ Vista Gold Corp

Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects. The company evaluate, acquire, explore and advance gold exploration and potential development projects, which may lead to gold production or value adding strategic transactions. These activities are currently focused principally in Australia.

Share on Social Networks: